论文部分内容阅读
本文着重介绍了再生障碍性贫血(下简称再障)的免疫抑制疗法。免疫抑制疗法的依据同种骨髓移植的成功支持骨髓造血干细胞异常为再障的原因,然而,重症再障由一卵双生儿进行同种骨髓移植,约半数不能成功,在免疫抑制下进行再移植,仍有不少患者可获得成功。
This article highlights the immunosuppressive therapy of aplastic anemia (hereinafter referred to as aplastic anemia). Immunosuppressive therapy based on the success of allogeneic bone marrow transplantation in support of bone marrow hematopoietic stem cell abnormalities as the cause of aplastic anemia, however, severe aplastic anemia from a twin twins allogeneic bone marrow transplantation, about half can not be successful in immunosuppression re-transplant , There are still many patients can be successful.